– AFTER STANFORD UNIVERSITY, NEW PARTNERSHIPS IN PERSPECTIVE
On May 16th, we submitted an application for a grant of 1.8 million Euro from the European Commission as part of the NanoStress consortium. NanoStress is composed of CC & C, INSERM (Bichat Hospital, Paris), INSERM-Transfer, Bichat Hospital Pathology Department, the University of Mons in Belgium and the University of Patras in Greece. Thanks are in particular to Delphine Smagghe and the team of INSERM-Transfert whose technicality and commitment made it possible to meet deadlines. This first joint work between all the consortium members bodes well for the future.
The purpose of the experiment will be to demonstrate the action of our patented devices on human pancreatic cancer grafted into the pancreas of mice. The experiment will last two years with a publication of the final results expected in 2021. It will be a world first, since for the first time, we will demonstrate the therapeutic action of a stress field on a pancreatic tumor in vivo.